INTRODUCTION AND HYPOTHESIS: The objectives of this study are to investigate myofascial pain in patients with interstitial cystitis (IC) and to correlate myofascial exam findings with validated questionnaires. METHODS: A retrospective chart review was performed on 186 patients with a diagnosis of IC from April 2007 to December 2008. Demographics, history and physical examination, and validated pelvic floor dysfunction questionnaire scores were extracted. The data was evaluated with SPSS for Windows using Spearman's rho, Mann-Whitney, and Kruskal-Wallis statistical analyses. RESULTS: Myofascial pain was demonstrated in 78.3% of IC patients with at least one myofascial trigger point, and 67.9% of patients had numerous areas of trigger points. Mild correlations were seen with trigger points and scores from the PUF, PFDI-20, and PFIQ-7 questionnaires. CONCLUSIONS: Myofascial pain is prevalent among IC patients and positively correlated with pelvic floor dysfunction scores. These findings support evaluation of pelvic floor myofascial pain in IC patients and suggest a possible benefit from pelvic floor therapy.
INTRODUCTION AND HYPOTHESIS: The objectives of this study are to investigate myofascial pain in patients with interstitial cystitis (IC) and to correlate myofascial exam findings with validated questionnaires. METHODS: A retrospective chart review was performed on 186 patients with a diagnosis of IC from April 2007 to December 2008. Demographics, history and physical examination, and validated pelvic floor dysfunction questionnaire scores were extracted. The data was evaluated with SPSS for Windows using Spearman's rho, Mann-Whitney, and Kruskal-Wallis statistical analyses. RESULTS:Myofascial pain was demonstrated in 78.3% of IC patients with at least one myofascial trigger point, and 67.9% of patients had numerous areas of trigger points. Mild correlations were seen with trigger points and scores from the PUF, PFDI-20, and PFIQ-7 questionnaires. CONCLUSIONS:Myofascial pain is prevalent among IC patients and positively correlated with pelvic floor dysfunction scores. These findings support evaluation of pelvic floor myofascial pain in IC patients and suggest a possible benefit from pelvic floor therapy.
Authors: C Lowell Parsons; Jeffrey Dell; Edward J Stanford; Michael Bullen; Bruce S Kahn; Tracy Waxell; James A Koziol Journal: Urology Date: 2002-10 Impact factor: 2.649
Authors: Mary P FitzGerald; Rodney U Anderson; Jeannette Potts; Christopher K Payne; Kenneth M Peters; J Quentin Clemens; Rhonda Kotarinos; Laura Fraser; Annemarie Cosby; Carole Fortman; Cynthia Neville; Suzanne Badillo; Lisa Odabachian; Andrea Sanfield; Betsy O'Dougherty; Rick Halle-Podell; Liyi Cen; Shannon Chuai; J Richard Landis; Keith Mickelberg; Ted Barrell; John W Kusek; Leroy M Nyberg Journal: J Urol Date: 2009-06-17 Impact factor: 7.450
Authors: Kenneth M Peters; Donna J Carrico; Scott E Kalinowski; Ibrahim A Ibrahim; Ananias C Diokno Journal: Urology Date: 2007-07 Impact factor: 2.649
Authors: Charles N Rudick; Michael C Chen; Anne K Mongiu; David J Klumpp Journal: Am J Physiol Regul Integr Comp Physiol Date: 2007-07-11 Impact factor: 3.619
Authors: Lisa A Kilpatrick; Jason J Kutch; Kirsten Tillisch; Bruce D Naliboff; Jennifer S Labus; Zhiguo Jiang; Melissa A Farmer; A Vania Apkarian; Sean Mackey; Katherine T Martucci; Daniel J Clauw; Richard E Harris; Georg Deutsch; Timothy J Ness; Claire C Yang; Kenneth Maravilla; Chris Mullins; Emeran A Mayer Journal: J Urol Date: 2014-03-26 Impact factor: 7.450
Authors: Amos Adelowo; Michele R Hacker; Alex Shapiro; Anna Merport Modest; Eman Elkadry Journal: Female Pelvic Med Reconstr Surg Date: 2013 Sep-Oct Impact factor: 2.091
Authors: A Lenore Ackerman; Una J Lee; Forrest C Jellison; Nelly Tan; Maitraya Patel; Steven S Raman; Larissa V Rodriguez Journal: Int Urogynecol J Date: 2015-08-01 Impact factor: 2.894